The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II basket trial evaluating the efficacy of pembrolizumab (PE) combined with vorinostat (VO) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma (SCC).
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Frédéric Bigot
Honoraria - AstraZeneca; BMSi; Lilly; MSD
Consulting or Advisory Role - AstraZeneca
 
Damien Vansteene
Honoraria - Astellas Pharma; Merck; Theradial
 
Maud Kamal
Consulting or Advisory Role - Roche
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Luca Mazzarella
Consulting or Advisory Role - Further; Tethis
Patents, Royalties, Other Intellectual Property - Pending patent PCT/EP2021/059707
 
Christian Borel
Honoraria - Bristol-Myers Squibb; Merck KGaA; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA; MSD Oncology
Travel, Accommodations, Expenses - Merck KGaA; MSD Oncology
 
Raphael Chaltiel
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Carlos A. Gomez-Roca
Honoraria - Bristol-Myers Squibb; Eisai; Foundation Medicine; Genentech/Roche; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Ellipses Pharma; Macomics
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech
Travel, Accommodations, Expenses - MSD Oncology; Pierre Fabre; Roche/Genentech
 
Sophie Cousin
No Relationships to Disclose
 
Elodie Coquan
Honoraria - AstraZeneca; Janssen Oncology
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Ipsen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Aurélien Lambert
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca/MedImmune; Bayer; GlaxoSmithKline; Ipsen; Janssen; Merck KGaA; Merck Serono; Novartis; Pierre Fabre; Servier/Pfizer
Travel, Accommodations, Expenses - Merck KGaA; Pfizer
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Xavier Durando
No Relationships to Disclose
 
François Legrand
No Relationships to Disclose
 
Amellie Lusque
No Relationships to Disclose
 
Fabrice Andre
Stock and Other Ownership Interests - PEGASCY
Consulting or Advisory Role - Gilead Sciences (Inst); Guardant Health (Inst); MEDIMMUNE (Inst); Relay therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Thomas Filleron
Consulting or Advisory Role - Cellectis (Inst)
Research Funding - Bristol Myers Squibb Foundation (Inst); Bristol Myers Squibb Foundation (Inst)